Skip to main content
Clinical Trials/NL-OMON21659
NL-OMON21659
Not yet recruiting
Not Applicable

Evaluation of the relationship between AGEs and treatmentresponsiveness of anti-VEGF in DME patients’

GSMS0 sites70 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
diabetic retinopathy (DR)
Sponsor
GSMS
Enrollment
70
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
GSMS

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with DME who started inravitreal anti\-VEGF therapy less than 1 yr ago
  • · Age: \>18 years.

Exclusion Criteria

  • Dark coloured skin (Fitzpatrick type V or VI).
  • · Skin abnormalities on both arms that will impair the reliability of the autofluorescence
  • measurement.
  • · Local or general active infection or inflammatory disease.
  • · Known renal disease, current dialysis treatment, or a history of renal transplantation.
  • · Patients with high myopia (\>6 diopters), glaucoma, combined retinal disease, media
  • opacities interfering with OCT imaging, vitreomacular traction on SD\-OCT and those
  • whose SD\-OCT images were of poor quality, intraocular surgery within 12 weeks prior
  • to the first injection

Outcomes

Primary Outcomes

Not specified

Similar Trials